“…They speculated that high titre MLV vaccines might be superior to others. In independent studies, other researchers concluded that seroconversion rates attained in their studies despite high MDA were dose related (Burtonboy et al, 1991;Hoare et al, 1997;Martella et al, 2005). Nevertheless, the titre in a vaccine may be meaningless if the minimum protective dose is not known (Appel, 1999), suggesting that over-attenuated virus may have a high titre in tissue culture but may not be adequately immunogenic.…”